The preset invention relates to an oral vaccine with an enhanced protective efficacy for aquatic animals comprising an antigen, which is expressed in Listonella sp., such as L. anguillarum, as an expression host transformed with an expression vector comprising the nucleic acid encoding the antigen, such as a viral subunit.
